These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23487209)

  • 21. [Non-dopaminergic treatments for Parkinson's disease].
    Derkinderen P
    Rev Neurol (Paris); 2010 Oct; 166(10):811-5. PubMed ID: 20832090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electromyography parameters of muscular fatigue and recovery in patients with Parkinson's disease before and on medication].
    Antonen EG; Meĭgal AIu; Lupandin IuV
    Fiziol Cheloveka; 2005; 31(4):81-7. PubMed ID: 16122039
    [No Abstract]   [Full Text] [Related]  

  • 23. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 24. [Parkinson's disease, familial Parkinson's disease].
    Kondo T
    Nihon Rinsho; 2004 Jan; 62 Suppl():97-101. PubMed ID: 15011328
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of new pharmacological approaches in Parkinson's disease.
    Carlsson A
    Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631
    [No Abstract]   [Full Text] [Related]  

  • 27. The postanesthesia patient with Parkinson's disease.
    Toledo LW
    J Post Anesth Nurs; 1992 Feb; 7(1):32-7. PubMed ID: 1531238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis and basis of the therapy of Parkinson's disease].
    van der Drift JH; Stoof JC
    Ned Tijdschr Geneeskd; 1981 Apr; 125(16):620-5. PubMed ID: 6113554
    [No Abstract]   [Full Text] [Related]  

  • 30. Motor fluctuations in Parkinson's disease.
    Crabb L
    Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication adherence in Parkinson's.
    Wright J; Walker J
    Br J Nurs; 2013 Jun 27-Jul 10; 22(12):686-9. PubMed ID: 24151705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic progress--review XX. Drug treatment of Parkinson's disease.
    Pall HS; Williams AC; Ramsden DB
    J Clin Hosp Pharm; 1986 Aug; 11(4):229-36. PubMed ID: 3531240
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
    Nepoklonov AV; Kapitsa IG; Ivanova EA; Voronina TA; Val'dman EA
    Eksp Klin Farmakol; 2012; 75(11):3-6. PubMed ID: 23323324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's focus. Parkinson's is debilitating but new treatments are on the horizon.
    Hermanns M
    RN; 2008 Oct; 71(10):24-8; quiz 29. PubMed ID: 18942321
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nursing process: nursing of patients with Parkinson's disease. Nursing before and after withdrawal for the purpose of medication control of patients with Parkinson's disease].
    Kanagawa M; Osaga W; Ishii T; Saika M; Ishii T
    Kurinikaru Sutadi; 1985 Aug; 6(8):933-9. PubMed ID: 3850295
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of Parkinson syndrome].
    Clarenbach P; Fröscher W
    Fortschr Med; 1986 Nov; 104(44):857-61. PubMed ID: 3804157
    [No Abstract]   [Full Text] [Related]  

  • 37. Rasagiline in Parkinson's disease: the show must go on.
    Jost WH
    Expert Opin Drug Saf; 2013 Nov; 12(6):797-800. PubMed ID: 23909684
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinsonism and Parkinson's disease.
    Janko KA; Shannon KM
    Nurse Pract Forum; 1996 Dec; 7(4):174-8. PubMed ID: 9043297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding Parkinson's disease.
    Noble C
    Nurs Stand; 2007 May 2-8; 21(34):48-56; quiz 58. PubMed ID: 17518075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.